Genetic Signatures Limited

ASX:GSS 株式レポート

時価総額:AU$162.8m

Genetic Signatures 過去の業績

過去 基準チェック /06

Genetic Signaturesの収益は年間平均-51.4%の割合で減少していますが、 Life Sciences業界の収益は年間 増加しています。収益は年間15.4% 7.8%割合で 増加しています。

主要情報

-51.4%

収益成長率

-45.1%

EPS成長率

Life Sciences 業界の成長19.7%
収益成長率7.8%
株主資本利益率-29.2%
ネット・マージン-129.7%
前回の決算情報30 Jun 2024

最近の業績更新

Recent updates

Getting In Cheap On Genetic Signatures Limited (ASX:GSS) Might Be Difficult

Jun 14
Getting In Cheap On Genetic Signatures Limited (ASX:GSS) Might Be Difficult

After Leaping 42% Genetic Signatures Limited (ASX:GSS) Shares Are Not Flying Under The Radar

Mar 08
After Leaping 42% Genetic Signatures Limited (ASX:GSS) Shares Are Not Flying Under The Radar

A Look At The Fair Value Of Genetic Signatures Limited (ASX:GSS)

Nov 14
A Look At The Fair Value Of Genetic Signatures Limited (ASX:GSS)

Genetic Signatures Limited (ASX:GSS) Investors Are Less Pessimistic Than Expected

Oct 10
Genetic Signatures Limited (ASX:GSS) Investors Are Less Pessimistic Than Expected

One Genetic Signatures Limited (ASX:GSS) Analyst Just Made A Major Cut To Next Year's Estimates

Jun 29
One Genetic Signatures Limited (ASX:GSS) Analyst Just Made A Major Cut To Next Year's Estimates

Genetic Signatures (ASX:GSS) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of

Feb 28
Genetic Signatures (ASX:GSS) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of

AU$3.20: That's What Analysts Think Genetic Signatures Limited (ASX:GSS) Is Worth After Its Latest Results

Feb 25
AU$3.20: That's What Analysts Think Genetic Signatures Limited (ASX:GSS) Is Worth After Its Latest Results

What Kind Of Shareholders Hold The Majority In Genetic Signatures Limited's (ASX:GSS) Shares?

Feb 07
What Kind Of Shareholders Hold The Majority In Genetic Signatures Limited's (ASX:GSS) Shares?

What Does Genetic Signatures' (ASX:GSS) CEO Pay Reveal?

Jan 17
What Does Genetic Signatures' (ASX:GSS) CEO Pay Reveal?

Genetic Signatures' (ASX:GSS) Wonderful 522% Share Price Increase Shows How Capitalism Can Build Wealth

Dec 27
Genetic Signatures' (ASX:GSS) Wonderful 522% Share Price Increase Shows How Capitalism Can Build Wealth

Genetic Signatures (ASX:GSS) Is In A Strong Position To Grow Its Business

Dec 06
Genetic Signatures (ASX:GSS) Is In A Strong Position To Grow Its Business

収支内訳

Genetic Signatures の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。


収益と収入の歴史

ASX:GSS 収益、費用、利益 ( )AUD Millions
日付収益収益G+A経費研究開発費
30 Jun 2414-18190
31 Mar 2415-18200
31 Dec 2316-18210
30 Sep 2319-16200
30 Jun 2322-14190
31 Mar 2323-11180
31 Dec 2224-8170
30 Sep 2230-3160
30 Jun 22353150
31 Mar 22333140
31 Dec 21312130
30 Sep 21302130
30 Jun 21282120
31 Mar 21293110
31 Dec 20295110
30 Sep 2021190
30 Jun 2014-280
31 Mar 2011-370
31 Dec 197-460
30 Sep 197-460
30 Jun 197-360
31 Mar 197-350
31 Dec 186-350
30 Sep 185-350
30 Jun 185-350
31 Mar 185-350
31 Dec 175-340
30 Sep 174-340
30 Jun 174-340
31 Mar 174-340
31 Dec 164-340
30 Sep 163-340
30 Jun 163-340
31 Mar 163-340
31 Dec 153-330
30 Sep 152-330
30 Jun 152-330
30 Jun 141-210

質の高い収益: GSSは現在利益が出ていません。

利益率の向上: GSSは現在利益が出ていません。


フリー・キャッシュフローと収益の比較


過去の収益成長分析

収益動向: GSSは利益が出ておらず、過去 5 年間で損失は年間51.4%の割合で増加しています。

成長の加速: GSSの過去 1 年間の収益成長を 5 年間の平均と比較することはできません。現在は利益が出ていないためです。

収益対業界: GSSは利益が出ていないため、過去 1 年間の収益成長をLife Sciences業界 ( -3.9% ) と比較することは困難です。


株主資本利益率

高いROE: GSSは現在利益が出ていないため、自己資本利益率 ( -29.23% ) はマイナスです。


総資産利益率


使用総資本利益率


過去の好業績企業の発掘